Combined use of the two drug classes may enhance clinical outcomes in DKD
The incidence appears dose-dependent, with higher maintenance doses (10 mg and 15 mg weekly) associated with greater gastrointestinal symptom burden compared to the 2.5 mg starting dose
Both peptides are considered safe when prescribed and monitored by a qualified provider
Healthcare providers can assess whether mood changes represent: Medication-related effects potentially requiring dose adjustment or discontinuation (per FDA guidance, Zepbound should be discontinued if suicidal thoughts or behaviors occur) Underlying psychiatric conditions needing specific treatment Physiological factors such as thyroid dysfunction or nutritional deficiencies Situational stressors benefiting from counseling or support services For patients with established mental health care, coordination between prescribers becomes critical
Culling C (2013) Handbook of histopathological and histochemical techniques: including museum techniques Dawson TM, Dawson VL (2018) Nitric oxide signaling in neurodegeneration and cell death
investigated the absorption, distribution, and elimination of semaglutide by means of population pharmacokinetic models using data from clinical pharmacology trials conducted in patients with type 2 diabetes and healthy subjects [63]